Evidence-Based Knee Injections for the Management of Arthritis

被引:140
作者
Cheng, Olivia T. [1 ]
Souzdalnitski, Dmitri [1 ]
Vrooman, Bruce [1 ]
Cheng, Jianguo [1 ]
机构
[1] Cleveland Clin, Dept Pain Management, Cleveland, OH 44195 USA
基金
美国国家卫生研究院;
关键词
Knee Injection; Rheumatoid Arthritis (RA); Osteoarthritic (OA); Juvenile Rheumatoid Arthritis (JRA); Intraarticular Corticosteroid Injection (IACI); Hyaluronic Acid (HA); Radiation Synovectomy (RSO); BOTULINUM-TOXIN-A; INTERLEUKIN-1 RECEPTOR ANTAGONIST; INTRAARTICULAR STEROID INJECTIONS; JUVENILE IDIOPATHIC ARTHRITIS; DOUBLE-BLIND; HYALURONIC-ACID; RHEUMATOID-ARTHRITIS; RADIATION SYNOVECTOMY; OSTEOARTHRITIS; JOINT;
D O I
10.1111/j.1526-4637.2012.01394.x
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Objective. Arthritis of the knee affects 46 million Americans. We aimed to determine the level of evidence of intraarticular knee injections in the management of arthritic knee pain. Methods. We systematically searched PUBMED/MEDLINE and the Cochrane databases for articles published on knee injections and evaluated their level of evidence and recommendations according to established criteria. Results. The evidence supports the use of intraarticular corticosteroid injections for rheumatoid arthritis (1A+ Level), osteoarthritis (1A+ Level), and juvenile idiopathic arthritis (2C+ Level). Pain relief and functional improvement are significant for months up to 1 year after the injection. Triamcinolone hexacetonide offers an advantage over triamcinolone acetonide and should be the intraarticular steroid of choice (2B+ Level). Intraarticular injection of hyaluronate may provide longer pain relief than steroid injection in osteoarthritis (2B+ Level). It can also be effective for rheumatoid arthritis knee pain (1A+ Level). However, it is only recommended for patients with significant surgical risk factors and for patients with mild radiographic disease in whom conservative treatment has failed (2B +/- Level). Botulinum toxin type A injection is effective in reducing arthritic knee pain (2B+ Level), and so is tropisetron (2B+ Level) and tanezumab (2B+ Level). The new agents, such as rAAV2-TNFR:Fc, SB-210396/CE 9.1, and various radioisotopes have provided various degrees of success, but their long-term safety and efficacy remains to be determined. Conclusions. We conclude that strong evidence supports the use of intraarticular knee injection as a valuable intervention in the continuum of management of arthritis between conservative treatment and knee surgeries.
引用
收藏
页码:740 / 753
页数:14
相关论文
共 102 条
[1]
A Double-Blind, Randomized, Saline-Controlled Study of the Efficacy and Safety of EUFLEXXA® for Treatment of Painful Osteoarthritis of the Knee, With an Open-Label Safety Extension (The FLEXX Trial) [J].
Altman, Roy D. ;
Rosen, Jeffrey E. ;
Bloch, Daniel A. ;
Hatoum, Hind T. ;
Korner, Paul .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 39 (01) :1-9
[2]
Long-distance retrograde effects of botulinum neurotoxin A [J].
Antonucci, Flavia ;
Rossi, Chiara ;
Gianfranceschi, Laura ;
Rossetto, Ornella ;
Caleo, Matteo .
JOURNAL OF NEUROSCIENCE, 2008, 28 (14) :3689-3696
[3]
Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A [J].
Aoki, KR .
NEUROTOXICOLOGY, 2005, 26 (05) :785-793
[4]
Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee:: systematic review and meta-analysis [J].
Arrich, J ;
Piribauer, F ;
Mad, P ;
Schmid, D ;
Klaushofer, K ;
Müllner, M .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (08) :1039-1043
[5]
Corticosteroid injections for osteoarthritis of the knee: meta-analysis [J].
Arroll, B ;
Goodyear-Smith, F .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7444) :869-870A
[6]
Efficacy of joint lavage in knee osteoarthritis: meta-analysis of randomized controlled studies [J].
Avouac, Jerome ;
Vicaut, Eric ;
Bardin, Thomas ;
Richette, Pascal .
RHEUMATOLOGY, 2010, 49 (02) :334-340
[7]
Bach-Rojecky L, 2005, CROAT MED J, V46, P201
[8]
Botulinum toxin type A in experimental neuropathic pain [J].
Bach-Rojecky, L ;
Relja, M ;
Lackovic, Z .
JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (02) :215-219
[9]
Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection [J].
Bach-Rojecky, Lidija ;
Salkovic-Petrisic, Melita ;
Lackovic, Zdravko .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 633 (1-3) :10-14
[10]
Central origin of the antinociceptive action of botulinum toxin type A [J].
Bach-Rojecky, Lidija ;
Lackovic, Zdravko .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 94 (02) :234-238